Home » Petition Urges Tighter Controls for Lab-Developed Tests
Petition Urges Tighter Controls for Lab-Developed Tests
January 13, 2009
The U.S. Food and Drug Administration’s (FDA) oversight of laboratory-developed tests (LDTs) for in vitro diagnostics (IVD) is fueling debate over whether the agency should create new, more stringent regulations.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor